Orthopedic market segment ranking open! Involving Johnson & Johnson, Medtronic, and Stryker

On the whole, the concentration of each segment industry is quite high, and the listed enterprises basically account for 80% - 90% of the share of each segment field; especially the top enterprises, which can't be surpassed for a long time, but our Chinese enterprises have initially possessed the strength to participate in international competition Orthopedic medical devices, as one of the important sub industries of the medical device industry, has always been an important part of the industry competition From the perspective of orthopedic medical subdivisions, the scale of trauma products accounts for a relatively high proportion, and the growth rate of spine and joint products is relatively fast According to the public data, in terms of market penetration, the market penetration rates of trauma, spine and joint in China are 4.9%, 1.5% and 0.6% respectively, and those in the United States are 66%, 38% and 43% respectively Compared with the developed countries, China still has a large gap and great development potential in the future The number of osteoporosis patients in China is increasing continuously According to the data of China osteoporosis white paper, the number of osteoporosis patients in China is close to 70 million According to the data of China Special Committee for surgical implants, by 2050, the number of osteoporosis patients in China will increase to 212 million, accounting for about 13.2% of the total population, while more than 30% of the elderly fracture patients are related to osteoporosis In addition, at present, there are more than 80 million severe patients with various kinds of arthritis in China, and there are about 750000 patients with mutilation At the same time, there are about 3 million new patients with bone injury every year With the acceleration of the aging process in China, the number of orthopedic diseases in China will grow rapidly, which will accelerate the expansion of orthopedic medical device market In recent years, the domestic medical device industry has developed rapidly, mainly focusing on low-end imitation products In the field of high-end medical devices, imported brands account for nearly 70% of China's high-end medical device products, such as MRI, CT, MI and other high-performance products are mostly imported Although the product quality has been continuously improved in recent years, it does not have international competitiveness In the future, with the support of policies, the orthopedic medical device industry is expected to usher in a new round of development space From the perspective of global market, the global orthopedic devices, with a market scale of US $51 billion, have long ranked among the four largest medical device industries (the other three areas are IVD diagnosis, cardiovascular, medical imaging), while the orthopedic devices are subdivided into five categories of products, including artificial joints (hip, knee, hand and foot joints), spine, trauma, sports medicine, bone biomaterials, etc The proportion of each category in 2018 is as follows: It can be seen that the artificial joint is still the largest category, accounting for 37% with us $18.9 billion (including US $9.1 billion for knee joint, US $7.6 billion for hip joint and US $2.3 billion for hand foot joint) The second is spinal implants, which account for 18% with us $9.3 billion; the third is trauma, which account for 14% with us $7.2 billion; the fourth is sports medicine, which account for 11% with us $5.6 billion; the fifth is bone biomaterials, which account for 10% with us $5.1 billion; the remaining other categories, which account for 10% The first group in joint field is composed of four traditional giants, accounting for 74% of the whole market share The first Gemma bangmei leads with us $5.1 billion, and has been the top player in the joint field for many years The fourth Smith & nephew also crushed the fifth Wright with nearly four times of the volume; The second camp consists of 12 enterprises with more than $100 million in revenue, which are also well-known in their respective advantageous markets or products; This year, the top 18 joint companies accounted for nearly 90% of the whole joint market with nearly 17 billion US dollars of revenue, and two Chinese enterprises, Shanghai minimally invasive and Aikang medical, were shortlisted Revenue unit: US $100 million In recent years, with the development of technology and the improvement of patients' requirements, the small joint market has developed rapidly; especially, Wright's strategy, which abandons the large joint products and focuses on the small joint, has successfully become one of the three giants in the small joint field (Johnson & Johnson, gemel, Wright), and the momentum of the latter is very obvious Revenue unit: US $100 million As the second largest orthopaedic segment, spine still shows slow market growth, mainly because the slow or even negative growth of top companies will continue to offset the growth of more concentrated middle end spine companies In addition, the field shows high activity In recent years, spine field has become a mature stage for M & A, cooperation and financing activities, which makes the market segment attractive to small companies seeking to enter and potentially exit the market Medtronic is still the first in spine category, and the second camp has changed a lot At present, Medtronic is composed of four enterprises (with 31% market share), namely Newcastle, Stryker, globus and gemel Because there are many enterprises with the amount of USD 50 million or less in the spine field, only enterprises with the amount of USD 60 million or more are included in the 2018 spine top 16, excluding the six largest enterprises in the head (accounting for 74% of the USD 9.3 billion in the spine market) China wego successfully ranked 12th with its single market Revenue unit: US $100 million The trauma market of more than 7 billion US dollars is crowded with too many competitors, but the head market is the same as the spine market After the merger of trauma king hindis, super giant Johnson and Johnson, with nearly 2.6 billion US dollars, occupied nearly 36% of the market share China's two enterprises, Dabo and Weigao, have reached the top 15 with outstanding encirclement Revenue unit: US $100 million Due to the change of global lifestyle and the increase of sports injury cases, the demand for sports medicine is rising rapidly, which has attracted many domestic peers or investors to enter the field However, this market is highly concentrated, and sports medicine needs a high investment in education and training and time, which requires a high standard of living market as the basis Globally, this market is dominated by five major companies, especially Ruishi and Smith & nephew, such as duopoly Medtronic and Johnson & Johnson in spine field, with 57% market share of US $1.9 billion and US $1.3 billion respectively In the second camp, Johnson & Johnson, Stryker and Kangmei are also superior in strength, among which Kangmei is the only independent sports medicine company that can compete with Ruishi Revenue unit: US $100 million Bone biomaterials include tissue and bone substitutes for rapid restoration of ligaments, tendons, muscles and fractures, mainly including bone growth stimulants, tackifiers, synthetic bone substitutes, stem cells, allografts, etc In 2018, the global orthopaedic biomaterial market reached US $5.1 billion The rise in the prevalence of chronic arthritis and the increase in the elderly population are expected to drive the development of the global market In addition, the increasing demand for biopharmaceuticals and patient awareness for minimally invasive surgery are expected to drive the global market The surge in sports injuries is also expected to expand the global market for bone biomaterials However, orthopedic biomaterials are relatively new and less reimbursed, which may inhibit the global market Compared with other categories, the concentration of bone biomaterial market is relatively low The five largest biomaterial markets lack control in this respect The largest Medtronic market only accounts for a little more than 10% of the market share, and the latter one is relatively even without obvious gap In addition to a number of small-scale artificial bone or allogeneic bone enterprises in the domestic market, there are no powerful enterprises involved Revenue unit: US $100 million Along with the vigorous development of orthopedic equipment industry, of course, there are our heroes behind the scenes, the OEM enterprises of orthopedic products and tools In 2018, the top 15 OEM enterprises were basically enterprises with more than 100 million US dollars, many of which were super OEM enterprises manufacturing across many fields, such as electronics, aviation, medical and so on In particular, some of the electronic OEM enterprises represented by Jabil, with large scale and rich experience, have entered the field of medical OEM in recent years, which will have a huge role in promoting the existing industry At present, the whole industry is still dominated by American enterprises, some enterprises in Germany and France are also quite strong, and domestic enterprises are still in the initial stage Revenue unit: US $100 million On the whole, the concentration of each segment industry is quite high, and the listed enterprises basically account for 80% - 90% of the share of each segment field; especially the top enterprises, which can't surpass for a long time, but our Chinese enterprises have initially possessed the strength to participate in international competition.